Cigna insider plans sale of 2,677 shares

Cigna Group (CI) insider Nicole S. Jones filed a Rule 144 notice covering planned sales of common stock.

Rhea-AI Filing Summary

Cigna Group (CI) insider Nicole S. Jones filed a Rule 144 notice covering planned sales of common stock. The filing lists a planned stock option exercise and potential sale of 2,677 shares of Cigna common stock on 08/18/2025, for cash, through Fidelity Brokerage Services LLC. It also reports that during the past three months, Jones sold 19,436 shares of Cigna common stock for aggregate proceeds of $5,369,583.72.

Key Figures

Planned shares to be sold: 2,677 shares Past 3-month shares sold: 19,436 shares Past 3-month sale proceeds: $5,369,583.72 +2 more

5 metrics

Planned shares to be sold 2,677 shares Common stock tied to a stock option exercise dated 08/18/2025

Past 3-month shares sold 19,436 shares Cigna Group common stock sold by Nicole S. Jones during the past 3 months

Past 3-month sale proceeds $5,369,583.72 Aggregate proceeds from 19,436 Cigna Group shares sold on 08/04/2026

Planned option exercise date 08/18/2025 Date of stock option exercise related to 2,677 shares

Issuer phone number 8602266000 Cigna Group issuer contact phone

Key Terms

Rule 144, stock option exercise, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

stock option exercise financial

"Common | 08/18/2025 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

attorney-in-fact regulatory

"as attorney-in-fact for Nicole S. Jones."

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing by Nicole S. Jones mean for Cigna Group (CI)?

The filing discloses that Nicole S. Jones plans to sell 2,677 shares of Cigna Group common stock after a stock option exercise on 08/18/2025, as required under Rule 144 for certain insider and affiliate sales.

How many Cigna Group (CI) shares is Nicole S. Jones planning to sell under this Form 144?

The notice covers a potential sale of 2,677 shares of Cigna Group common stock. These shares are tied to a stock option exercise dated 08/18/2025 and are to be sold for cash, subject to Rule 144 conditions.

What Cigna Group (CI) insider sales has Nicole S. Jones made in the past 3 months?

Over the past three months, Nicole S. Jones has sold 19,436 shares of Cigna Group common stock, with aggregate sale proceeds of $5,369,583.72. These prior sales are reported as part of the Form 144 historical disclosure requirement.

On what date is the planned Cigna Group (CI) stock option exercise and sale for Nicole S. Jones?

The filing identifies 08/18/2025 as the date of the planned stock option exercise related to 2,677 shares of Cigna common stock, which are expected to be sold for cash under Rule 144 procedures.

Who is executing the planned Cigna Group (CI) share sale for Nicole S. Jones?

The shares are associated with an account at Fidelity Brokerage Services LLC, and the Form 144 is signed by Jessica Spraker as a duly authorized representative and attorney-in-fact for Nicole S. Jones.

What type of Cigna Group (CI) security is covered by this Form 144 filing?

The filing covers common stock of Cigna Group. It details a planned stock option exercise and subsequent cash sale of 2,677 common shares on 08/18/2025, plus past three-month sales information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 11:40 AM Accepted by SEC EDGAR 08/18/2026 - 11:40 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001492663
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cigna Group
SEC File Number	001-38769
Address of Issuer	900 COTTAGE GROVE ROAD BLOOMFIELD CONNECTICUT 06002
Phone	8602266000
Name of Person for Whose Account the Securities are To Be Sold	Jones Nicole S
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2677	748415.71	264240486	08/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/18/2025	Stock Option Exercise	Issuer			2677	08/18/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Nicole S. Jones 900 COTTAGE GROVE ROAD BLOOMFIELD CT 06002	Common	08/04/2026	19436	5369583.72

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Nicole S. Jones.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)